Drug firm Natco Pharma today reported a 93.27 per cent rise in its consolidated net profit to Rs 181.1 crore for the quarter ended June 30 mainly on account of robust sales.
The company had posted a net profit of Rs 93.7 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.
Consolidated total revenue of the company stood at Rs 574.5 crore for the quarter under consideration. It was Rs 448.7 crore in the corresponding period of the previous fiscal.
The company's board of directors have approved an interim dividend of Rs 1.50 per equity share of Rs 2 each, Natco Pharma said.
Shares of Natco Pharma today closed 0.06 per cent lower at Rs 812.85 per scrip on the BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app